[Answered] A maple leaf is at which level in the hierarchy of biological organization?

This topic contains a solution. Click here to go to the answer

Author Question: A maple leaf is at which level in the hierarchy of biological organization? (Read 1808 times)

Hawke

Hero Member
Posts: 679

on: May 23, 2013

A maple leaf is at which level in the hierarchy of biological organization?
A) tissue
B) cell
C) organelle
D) organ
E) organ system

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by Celeste on May 24, 2019

Celeste

Hero Member
Posts: 588

Reply #1 on: May 24, 2019

(D)

Hawke

Member
Posts: 679

Reply 2 on: May 23, 2013

YES! Correct, THANKS for helping me on my review

Member
Posts:

Reply 3 on: Yesterday

Gracias!

« previous next »

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.